Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H26N2O2.ClH |
| Molecular Weight | 314.851 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(CN(C)C)(CN(C)C)OC(=O)C1=CC=CC=C1
InChI
InChIKey=FHHDPMSYDYZLAP-UHFFFAOYSA-N
InChI=1S/C16H26N2O2.ClH/c1-6-16(12-17(2)3,13-18(4)5)20-15(19)14-10-8-7-9-11-14;/h7-11H,6,12-13H2,1-5H3;1H
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
2 % 1 times / day single, intraurethral Recommended Dose: 2 %, 1 times / day Route: intraurethral Route: single Dose: 2 %, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Age Group: adult Sex: M Population Size: 2 Sources: |
Other AEs: Spasms, Cyanosis... Other AEs: Spasms Sources: Cyanosis Respiration spontaneous decreased |
10 % 1 times / day single, intraurethral Studied dose Dose: 10 %, 1 times / day Route: intraurethral Route: single Dose: 10 %, 1 times / day Sources: |
healthy, adult n = 3 Health Status: healthy Age Group: adult Sex: M Population Size: 3 Sources: |
Other AEs: Generalised convulsion, Respiration spontaneous decreased... Other AEs: Generalised convulsion Sources: Respiration spontaneous decreased Cyanosis |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Cyanosis | 2 % 1 times / day single, intraurethral Recommended Dose: 2 %, 1 times / day Route: intraurethral Route: single Dose: 2 %, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Age Group: adult Sex: M Population Size: 2 Sources: |
|
| Respiration spontaneous decreased | 2 % 1 times / day single, intraurethral Recommended Dose: 2 %, 1 times / day Route: intraurethral Route: single Dose: 2 %, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Age Group: adult Sex: M Population Size: 2 Sources: |
|
| Spasms | 2 % 1 times / day single, intraurethral Recommended Dose: 2 %, 1 times / day Route: intraurethral Route: single Dose: 2 %, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Age Group: adult Sex: M Population Size: 2 Sources: |
|
| Cyanosis | 10 % 1 times / day single, intraurethral Studied dose Dose: 10 %, 1 times / day Route: intraurethral Route: single Dose: 10 %, 1 times / day Sources: |
healthy, adult n = 3 Health Status: healthy Age Group: adult Sex: M Population Size: 3 Sources: |
|
| Generalised convulsion | 10 % 1 times / day single, intraurethral Studied dose Dose: 10 %, 1 times / day Route: intraurethral Route: single Dose: 10 %, 1 times / day Sources: |
healthy, adult n = 3 Health Status: healthy Age Group: adult Sex: M Population Size: 3 Sources: |
|
| Respiration spontaneous decreased | 10 % 1 times / day single, intraurethral Studied dose Dose: 10 %, 1 times / day Route: intraurethral Route: single Dose: 10 %, 1 times / day Sources: |
healthy, adult n = 3 Health Status: healthy Age Group: adult Sex: M Population Size: 3 Sources: |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
631-38-9
Created by
admin on Sat Dec 16 09:42:20 GMT 2023 , Edited by admin on Sat Dec 16 09:42:20 GMT 2023
|
PRIMARY | |||
|
06F0ZZ018S
Created by
admin on Sat Dec 16 09:42:20 GMT 2023 , Edited by admin on Sat Dec 16 09:42:20 GMT 2023
|
PRIMARY | |||
|
211-156-6
Created by
admin on Sat Dec 16 09:42:20 GMT 2023 , Edited by admin on Sat Dec 16 09:42:20 GMT 2023
|
PRIMARY | |||
|
74195-82-7
Created by
admin on Sat Dec 16 09:42:20 GMT 2023 , Edited by admin on Sat Dec 16 09:42:20 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
12427
Created by
admin on Sat Dec 16 09:42:20 GMT 2023 , Edited by admin on Sat Dec 16 09:42:20 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
